Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ACHC Stock Forecast 2025-2026
$24.36
Current Price
$2.24B
Market Cap
Buy 10
Hold 4
Sell 0
Wall St Analyst Ratings
Distance to ACHC Price Targets
+195.6%
To High Target of $72.00
+64.2%
To Median Target of $40.00
+14.9%
To Low Target of $28.00
ACHC Price Momentum
+4.5%
1 Week Change
+14.7%
1 Month Change
-63.7%
1 Year Change
-38.6%
Year-to-Date Change
-70.4%
From 52W High of $82.41
+19.6%
From 52W Low of $20.36
📊 TOP ANALYST CALLS
Did ACHC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Acadia Healthcare is one of their latest high-conviction picks.
Latest ACHC Stock Price Targets & Analyst Predictions
Based on our analysis of 25 Wall Street analysts, ACHC has a bullish consensus with a median price target of $40.00 (ranging from $28.00 to $72.00). The overall analyst rating is Strong Buy (8.7/10). Currently trading at $24.36, the median forecast implies a 64.2% upside. This outlook is supported by 10 Buy, 4 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Andrew Mok at Barclays, suggesting a 14.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ACHC Analyst Ratings
10
Buy
4
Hold
0
Sell
ACHC Price Target Range
Low
$28.00
Average
$40.00
High
$72.00
Current: $24.36
Latest ACHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ACHC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 14, 2025 | Mizuho | Ann Hynes | Neutral | Maintains | $32.00 |
| May 14, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $55.00 |
| May 14, 2025 | Barclays | Andrew Mok | Equal-Weight | Maintains | $28.00 |
| Apr 9, 2025 | Guggenheim | Jason Cassorla | Buy | Initiates | $36.00 |
| Mar 25, 2025 | Mizuho | Ann Hynes | Neutral | Maintains | $37.00 |
| Mar 3, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $65.00 |
| Mar 3, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $43.00 |
| Feb 28, 2025 | Barclays | Andrew Mok | Equal-Weight | Downgrade | $35.00 |
| Feb 28, 2025 | B of A Securities | Kevin Fischbeck | Buy | Maintains | $44.50 |
| Jan 10, 2025 | RBC Capital | Ben Hendrix | Outperform | Reiterates | $64.00 |
| Jan 7, 2025 | Keybanc | Matthew Gillmor | Overweight | Upgrade | $70.00 |
| Jan 7, 2025 | TD Cowen | Ryan Langston | Buy | Maintains | $66.00 |
| Dec 12, 2024 | Deutsche Bank | Pito Chickering | Buy | Upgrade | $75.00 |
| Dec 10, 2024 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $52.00 |
| Nov 22, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $43.00 |
| Nov 18, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $64.00 |
| Oct 11, 2024 | Keybanc | Matthew Gillmor | Sector Weight | Initiates | $0.00 |
| Oct 4, 2024 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $90.00 |
| Oct 1, 2024 | Cantor Fitzgerald | Sarah James | Neutral | Reiterates | $90.00 |
| Sep 30, 2024 | Barclays | Andrew Mok | Overweight | Maintains | $76.00 |
Acadia Healthcare Company, Inc. (ACHC) Competitors
The following stocks are similar to Acadia Healthcare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ACHC
Acadia Healthcare
mkt cap
2.24B
Acadia Healthcare Company, Inc. (ACHC) Financial Data
Acadia Healthcare Company, Inc. has a market capitalization of $2.24B with a P/E ratio of 11.9x. The company generates $3.16B in trailing twelve-month revenue with a 5.9% profit margin.
Revenue growth is +0.3% quarter-over-quarter, while maintaining an operating margin of +10.2% and return on equity of +6.3%.
Valuation Metrics
Market Cap
$2.24B
Enterprise Value
$4.48B
P/E Ratio
11.9x
PEG Ratio
6.6x
Price/Sales
0.7x
Growth & Margins
Revenue Growth (YoY)
+0.3%
Gross Margin
+96.3%
Operating Margin
+10.2%
Net Margin
+5.9%
EPS Growth
-89.0%
Financial Health
Cash/Price Ratio
+4.1%
Current Ratio
1.4x
Debt/Equity
74.1x
ROE
+6.3%
ROA
+5.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Acadia Healthcare Company, Inc. (ACHC) Business Model
About Acadia Healthcare Company, Inc.
What They Do
Provides behavioral healthcare services across the US and UK.
Business Model
Acadia Healthcare operates a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic school-based programs, generating revenue by offering a wide range of mental health and addiction treatment services. The company focuses on quality care, catering to the growing demand for mental health services, which positions it favorably in the healthcare market.
Additional Information
As societal stigma around mental health decreases, Acadia's services become increasingly vital. The company also collaborates with government health agencies to enhance access to care for underserved populations.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
25,500
CEO
Mr. Christopher Howal Hunter
Country
United States
IPO Year
1994
Website
www.acadiahealthcare.comAcadia Healthcare Company, Inc. (ACHC) Latest News & Analysis
Latest News
Quick Summary
The Big Beautiful Bill supports defense and manufacturing sectors, while healthcare and some REITs struggle with Medicaid cuts. AI optimism drives a market rally, with META, MSFT, NVDA, and AMZN as leading stocks.
Why It Matters
The Big Beautiful Bill shifts investment focus to defense and industrials, while healthcare and REITs struggle. AI stock valuations may indicate a bubble, impacting future market performance.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Investors should monitor ACHC stock due to notable activity in the options market recently.
Why It Matters
Increased activity in the options market for ACHC stock may indicate heightened investor sentiment or expectations of volatility, influencing trading strategies and stock performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
The "One Big Beautiful Bill" is nearing passage and may affect the economy and specific sectors, potentially impacting some dividend stocks negatively while benefiting others.
Why It Matters
The potential passage of the "One Big Beautiful Bill" could reshape sectors, affecting dividend stock performance. Investors may need to reevaluate their portfolios based on these shifts.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for Acadia Healthcare investors who bought shares before February 28, 2020. Interested parties can visit bgandg.com/ACHC for details.
Why It Matters
The investigation may indicate potential legal issues for Acadia Healthcare, impacting stock performance and investor confidence. Increased scrutiny could lead to volatility in its share price.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for Acadia Healthcare investors who bought shares before February 28, 2020. Further details can be found at bgandg.com/ACHC.
Why It Matters
The investigation into Acadia Healthcare may indicate potential legal or financial issues, impacting stock value and investor sentiment. Ongoing scrutiny could affect future performance and stability.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for Acadia Healthcare investors who purchased shares before February 28, 2020. More info available at bgandg.com/ACHC.
Why It Matters
The investigation into Acadia Healthcare may indicate potential legal issues, affecting stock performance and investor sentiment, leading to volatility in ACHC's share price.
Source: Accesswire
Market Sentiment:
Neutral
Frequently Asked Questions About ACHC Stock
What is Acadia Healthcare Company, Inc.'s (ACHC) stock forecast for 2026?
Based on our analysis of 25 Wall Street analysts, Acadia Healthcare Company, Inc. (ACHC) has a median price target of $40.00. The highest price target is $72.00 and the lowest is $28.00.
Is ACHC stock a good investment in 2026?
According to current analyst ratings, ACHC has 10 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $24.36. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ACHC stock?
Wall Street analysts predict ACHC stock could reach $40.00 in the next 12 months. This represents a 64.2% increase from the current price of $24.36. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Acadia Healthcare Company, Inc.'s business model?
Acadia Healthcare operates a network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic school-based programs, generating revenue by offering a wide range of mental health and addiction treatment services. The company focuses on quality care, catering to the growing demand for mental health services, which positions it favorably in the healthcare market.
What is the highest forecasted price for ACHC Acadia Healthcare Company, Inc.?
Price targets from Wall Street analysts for ACHC are not currently available. The stock is trading at $24.36.
What is the lowest forecasted price for ACHC Acadia Healthcare Company, Inc.?
The lowest price target for ACHC is $28.00 from Andrew Mok at Barclays, which represents a 14.9% increase from the current price of $24.36.
What is the overall ACHC consensus from analysts for Acadia Healthcare Company, Inc.?
The overall analyst consensus for ACHC is bullish. Out of 25 Wall Street analysts, 10 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $40.00.
How accurate are ACHC stock price projections?
Stock price projections, including those for Acadia Healthcare Company, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 14, 2025 2:01 AM UTC